Related Experiment Videos
A case of ichthyosis linearis circumflexa successfully treated with topical tacrolimus
Y Suga1, R Tsuboi, Y Hashimoto
1Department of Dermatology, Juntendo University School of Medicine, Tokyo, Japan.
Journal of the American Academy of Dermatology
|February 25, 2000
Insights
Ichthyosis linearis circumflexa (ILC) can occur without typical atopic symptoms or hair deformities. Topical tacrolimus treatment suggests immune system involvement in ILC development.
Area of Science:
- Dermatology
- Immunology
Background:
- Ichthyosis linearis circumflexa (ILC) is a rare genetic skin disorder.
- Typically presents with characteristic scaling patterns and often associated with atopic conditions and hair shaft abnormalities.
Observation:
- A case of ILC was observed without the usual atopic manifestations.
- The patient did not exhibit the typical deformities of the hair shaft.
Findings:
- The patient showed a positive response to treatment with topical tacrolimus.
- This suggests a potential role for immunoregulatory mechanisms in the pathogenesis of ILC.
Implications:
- The findings suggest that ILC may have an immune-mediated component.
- Topical immunomodulators like tacrolimus could be a viable treatment option for ILC.
- Further research into the immunopathogenesis of ILC is warranted.
Abstract:
We report a case of ichthyosis linearis circumflexa (ILC) without the typical atopic manifestations and deformities of the hair shaft. The patient responded positively to treatment with topical tacrolimus, suggesting that abnormalities in the immunoregulatory mechanism may be involved in the pathogenesis of ILC.